CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 72 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,000 | -68.2% | 25,350 | +23.1% | 0.00% | – |
| Q1 2019 | $22,000 | -56.9% | 20,601 | -29.5% | 0.00% | – |
| Q4 2018 | $51,000 | -93.5% | 29,221 | -78.5% | 0.00% | – |
| Q3 2018 | $788,000 | -56.1% | 135,778 | -67.6% | 0.00% | – |
| Q2 2018 | $1,794,000 | +249.0% | 418,995 | +378.7% | 0.00% | – |
| Q1 2018 | $514,000 | +50.7% | 87,520 | +18.7% | 0.00% | – |
| Q4 2017 | $341,000 | -13.2% | 73,751 | +2.9% | 0.00% | – |
| Q3 2017 | $393,000 | +8.3% | 71,652 | +13.8% | 0.00% | – |
| Q2 2017 | $363,000 | +322.1% | 62,977 | +323.0% | 0.00% | – |
| Q1 2017 | $86,000 | -74.0% | 14,887 | -76.3% | 0.00% | – |
| Q4 2016 | $331,000 | +903.0% | 62,736 | +280.9% | 0.00% | – |
| Q3 2016 | $33,000 | +13.8% | 16,472 | +17.3% | 0.00% | – |
| Q2 2016 | $29,000 | -76.0% | 14,047 | -28.9% | 0.00% | – |
| Q3 2014 | $121,000 | -31.2% | 19,770 | +2.5% | 0.00% | – |
| Q2 2014 | $176,000 | +8.0% | 19,284 | -3.5% | 0.00% | – |
| Q1 2014 | $163,000 | +14.8% | 19,976 | -9.5% | 0.00% | – |
| Q4 2013 | $142,000 | -66.0% | 22,068 | -46.9% | 0.00% | – |
| Q3 2013 | $418,000 | – | 41,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,464,807 | $14,468,000 | 5.57% |
| COURAGE CAPITAL MANAGEMENT LLC | 192,486 | $1,130,000 | 0.86% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 90,455 | $531,000 | 0.07% |
| Alambic Investment Management, L.P. | 86,204 | $506,000 | 0.07% |
| Kalos Management, Inc. | 30,000 | $164,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 32,394 | $190,000 | 0.03% |
| ELLINGTON MANAGEMENT GROUP LLC | 60,600 | $356,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 55,008 | $323,000 | 0.02% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $129,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 580,972 | $3,411,000 | 0.02% |